US Patent 10995147 Preparations and methods for treating a GD2 positive cancer

Patent 10995147 was granted and assigned to APEIRON Biologics on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Apeiron Biologics

Current Assignee

Apeiron Biologics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109951470

Patent Inventor Names

Ruth Ladenstein0

Hans Loibner0

Isabel Klier0

Oliver Mutschlechner0

Date of Patent

May 4, 2021

Patent Application Number

169208800

Date Filed

July 6, 2020

Patent Citations

‌

US Patent 10294305 Method for treating a GD2 positive cancer

Patent Primary Examiner

‌

Karen A. Canella

Patent abstract

A method of treating a high-risk neuroblastoma in a patient is described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10995147 Preparations and methods for treating a GD2 positive cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API